Harvard Bioscience
HBIO
#8966
Rank
C$0.13 B
Marketcap
$3.03
Share price
0.48%
Change (1 day)
-56.78%
Change (1 year)

Harvard Bioscience (HBIO) - Cash on Hand

Cash on Hand as of September 2024 : C$6.56 Million

According to Harvard Bioscience's latest financial reports the company has C$6.56 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Harvard Bioscience - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$5.68 M-7.13%
2022-12-31C$6.11 M-38.63%
2021-12-31C$9.96 M-6.01%
2020-12-31C$10.6 M-2.58%
2019-12-31C$10.88 M-2.22%
2018-12-31C$11.13 M70.56%
2017-12-31C$6.52 M-13.2%
2016-12-31C$7.52 M-19.62%
2015-12-31C$9.35 M-42.96%
2014-12-31C$16.4 M-40.21%
2013-12-31C$27.43 M33.4%
2012-12-31C$20.56 M12.85%
2011-12-31C$18.22 M-7.47%
2010-12-31C$19.69 M12.85%
2009-12-31C$17.45 M4.79%
2008-12-31C$16.65 M-6.67%
2007-12-31C$17.84 M63.81%
2006-12-31C$10.89 M22.61%
2005-12-31C$8.88 M-46.65%
2004-12-31C$16.65 M56.14%
2003-12-31C$10.66 M-55.9%
2002-12-31C$24.18 M-48.34%
2001-12-31C$46.81 M-12.76%
2000-12-31C$53.66 M1452.78%
1999-12-31C$3.45 M134.87%
1998-12-31C$1.47 M